Go Pro
NASDAQ:AVR

Anteris Technologies Global Q1 2025 Earnings Report

Anteris Technologies Global logo
$7.62 -0.51 (-6.27%)
Closing price 09/23/2026 04:00 PM Eastern
Extended Trading
$7.65 +0.03 (+0.39%)
As of 07:22 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Anteris Technologies Global EPS Results

Actual EPS
-$0.61
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Anteris Technologies Global Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Anteris Technologies Global Announcement Details

Quarter
Q1 2025
Time
After Market Closes
Conference Call Date
Wednesday, May 14, 2025
Conference Call Time
3:30AM ET

Upcoming Earnings

Anteris Technologies Global's Q3 2026 earnings is estimated for Wednesday, November 11, 2026, based on past reporting schedules, with a conference call scheduled on Tuesday, November 17, 2026 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Anteris Technologies Global Earnings Headlines

Anteris Extends Key Supply and Quality Agreement Term
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel
Anteris Technologies Global Corp. (AVR)
See More Anteris Technologies Global Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Anteris Technologies Global? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Anteris Technologies Global and other key companies, straight to your email.

About Anteris Technologies Global

Anteris Technologies Global (NASDAQ:AVR) is a medical device company focused on developing advanced technologies for structural heart disease. Its primary product candidate is the DurAVR transcatheter heart valve, designed to treat aortic valve stenosis through a minimally invasive transcatheter aortic valve replacement procedure.

The DurAVR valve is based on Anteris’ ADAPT tissue-engineering technology and is manufactured as a single-piece valve intended to replicate the performance and natural hemodynamics of a healthy human aortic valve. The company is also developing related delivery-system and structural-heart technologies to support the use of its valve platform.

Anteris has roots in Australia and operates internationally, with activities spanning research, product development, clinical evaluation and regulatory preparation. The company is led by Chief Executive Officer Wayne Paterson. Its products remain subject to applicable clinical and regulatory requirements before broad commercial availability.

View Anteris Technologies Global Profile